SCHEMBL6173115

SCHEMBL6173115

CC1(Cc2ccncc2NC(=O)c2cccc(Cl)c2)NC(=O)N(c2ccc(SC(F)(F)F)cc2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 6/20 0.39
KCNK2 O95069 2/20 0.38
KCNK10 P57789 2/20 0.38
ALDH1A1 P00352 3/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HSD17B13 Q7Z5P4 1/20 0.35
TEK Q02763 1/20 0.35
BRAF P15056 1/20 0.35
CXCR3 P49682 1/20 0.35
AR P10275 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173746 0.91 LMNA (0.42) IGF1RKCNK2KCNK10ALDH1A1MEN1
SCHEMBL6173492 0.91 KCNK2 (0.41) IGF1RKCNK2KCNK10ALDH1A1
SCHEMBL6175149 0.88 ALDH1A1 (0.42) ALDH1A1MEN1KMT2AHSD17B13BRAF
SCHEMBL6172432 0.87 ALDH1A1 (0.38) IGF1RALDH1A1MEN1KMT2AHSD17B13
SCHEMBL6173999 0.86 IGF1R (0.40) IGF1RKCNK2KCNK10ALDH1A1MEN1
SCHEMBL6174077 0.85 CYP3A4 (0.49) IGF1RKCNK2KCNK10ALDH1A1MEN1
SCHEMBL6176971 0.84 IGF1R (0.40) IGF1RMEN1KMT2A
SCHEMBL2937617 0.84 IGF1R (0.56) IGF1R
SCHEMBL6173726 0.82 IGF1R (0.42) IGF1RALDH1A1AR
SCHEMBL6171771 0.82 IGF1R (0.41) IGF1RMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed